Filters: Relation Is Part Of: "NANOS Annual Meeting 2018: Scientific Platform, Session I" Collection: "ehsl_novel_nam"
1 - 25 of 16
Number of results to display per page
TitleCreatorRelation Is Part Of
1 Assessment of a Fully-Automated RAPD Test as a Routine Screening ToolLael Stander; Shira Simon; Matthew Thurtell; Michael Wall; Randy KardonNANOS Annual Meeting 2018: Scientific Platform, Session I
2 Assessment of a Fully-Automated RAPD Test as a Routine Screening ToolLael Stander; Shira Simon; Matthew Thurtell; Michael Wall; Randy KardonNANOS Annual Meeting 2018: Scientific Platform, Session I
3 Does optic nerve appearance predict visual outcome in patients with idiopathic intracranial hypertension (IIH)?Jonathan Micieli; Beau Bruce; Caroline Vasseneix; Richard Blanch; Damian Berezovsky; Jason Peragallo; Nancy Newman; Valerie BiousseNANOS Annual Meeting 2018: Scientific Platform, Session I
4 Does optic nerve appearance predict visual outcome in patients with idiopathic intracranial hypertension (IIH)?Jonathan Micieli; Beau Bruce; Caroline Vasseneix; Richard Blanch; Damian Berezovsky; Jason Peragallo; Nancy Newman; Valerie BiousseNANOS Annual Meeting 2018: Scientific Platform, Session I
5 eFOCUS Phase 2: Comparative Clinical Performance of Smartphone & Traditional FunduscopyHamish Dunn; Samuel Marks; Kai Teo; Christine Kang; Stewart Dunn; Paul Healey; Andrew WhiteNANOS Annual Meeting 2018: Scientific Platform, Session I
6 eFOCUS Phase 2: Comparative Clinical Performance of Smartphone & Traditional FunduscopyHamish Dunn; Samuel Marks; Kai Teo; Christine Kang; Stewart Dunn; Paul Healey; Andrew WhiteNANOS Annual Meeting 2018: Scientific Platform, Session I
7 Interocular Phase Delay Shifts Visual Cortical Dominance: a Potential New Therapeutic Approach for AmblyopiaEric Gaier; Daniel Montgomery; Arnold Heynen; Mark BearNANOS Annual Meeting 2018: Scientific Platform, Session I
8 Interocular Phase Delay Shifts Visual Cortical Dominance: a Potential New Therapeutic Approach for AmblyopiaEric Gaier; Daniel Montgomery; Arnold Heynen; Mark BearNANOS Annual Meeting 2018: Scientific Platform, Session I
9 Next Generation Sequencing results in an Italian cohort of hereditary optic neuropathies patientsChiara La Morgia; Francesca Tagliavini; Leonardo Caporali; Michele Carbonelli; Lidia Di Vito; Piero Barboni; Maria Lucia Cascavilla; Arturo Carta; Alessandra Rufa; Stefania Bianchi Marzoli; Francesco Mari; Michelangelo Mancuso; Maria Alice Donati; Anna Maria De Negri; Federico Sadun; Maria Lucia Val...NANOS Annual Meeting 2018: Scientific Platform, Session I
10 Next Generation Sequencing results in an Italian cohort of hereditary optic neuropathies patientsChiara La Morgia; Francesca Tagliavini; Leonardo Caporali; Michele Carbonelli; Lidia Di Vito; Piero Barboni; Maria Lucia Cascavilla; Arturo Carta; Alessandra Rufa; Stefania Bianchi Marzoli; Francesco Mari; Michelangelo Mancuso; Maria Alice Donati; Anna Maria De Negri; Federico Sadun; Maria Lucia Val...NANOS Annual Meeting 2018: Scientific Platform, Session I
11 Ocular Motor Abnormalities during Saccadic Reading in Different Neuro-Ophthalmic DiseasesAngela Oh; Tiffany Chen; Mohammad Shariati; Naz Jehangir; Caroline Yu; Carmel Mercado; Rosa Yu; Joyce LiaoNANOS Annual Meeting 2018: Scientific Platform, Session I
12 Ocular Motor Abnormalities during Saccadic Reading in Different Neuro-Ophthalmic DiseasesAngela Oh; Tiffany Chen; Mohammad Shariati; Naz Jehangir; Caroline Yu; Carmel Mercado; Rosa Yu; Joyce LiaoNANOS Annual Meeting 2018: Scientific Platform, Session I
13 Safety and Efficacy of an 11β-Hydroxysteroid Dehydrogenase Type-1 Inhibitor (AZD4017) in Idiopathic Intracranial HypertensionKeira Markey; Ryan Ottridge; James Mitchell; Caroline Rick; Rebecca Woolley; Natalie Ives; Tim Matthews; Anita Krishnan; Pushkar Shah; William Scotton; Susan Mollan; Alex SinclairNANOS Annual Meeting 2018: Scientific Platform, Session I
14 Safety and Efficacy of an 11β-Hydroxysteroid Dehydrogenase Type-1 Inhibitor (AZD4017) in Idiopathic Intracranial HypertensionKeira Markey; Ryan Ottridge; James Mitchell; Caroline Rick; Rebecca Woolley; Natalie Ives; Tim Matthews; Anita Krishnan; Pushkar Shah; William Scotton; Susan Mollan; Alex SinclairNANOS Annual Meeting 2018: Scientific Platform, Session I
15 Safety/Acuity Outcomes 96-Weeks Post-Treatment with rAAV2/2-ND4; Gene Therapy for ND4 LHON: a Phase I/II TrialBarrett Katz; Catherine Vignal; Celine Bouquet; Nitza Thomasson; Ann Galy; Serge Fitoussi; Jose SahelNANOS Annual Meeting 2018: Scientific Platform, Session I
16 Safety/Acuity Outcomes 96-Weeks Post-Treatment with rAAV2/2-ND4; Gene Therapy for ND4 LHON: a Phase I/II TrialBarrett Katz; Catherine Vignal; Celine Bouquet; Nitza Thomasson; Ann Galy; Serge Fitoussi; Jose SahelNANOS Annual Meeting 2018: Scientific Platform, Session I
1 - 25 of 16